Legend Biotech Corp
NASDAQ:LEGN
Legend Biotech Corp
NASDAQ:LEGN
Price:
18.2
USD
-0.55%
Market Cap:
$3.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Legend Biotech Corp
NASDAQ:LEGN
|
US |
|
B
|
Barratt Developments P L C
F:3BA
|
UK |
|
M
|
Metso Oyj
OMXH:METSO
|
FI |
|
M
|
Meriaura Group Oyj
STO:MERIS
|
FI |
|
D
|
Daesung Holdings Co Ltd
KRX:016710
|
KR |
|
I
|
INOX India Ltd
NSE:INOXINDIA
|
IN |
|
E
|
Erin Ventures Inc
XTSX:EV
|
CA |
|
Tenfu (Cayman) Holdings Co Ltd
HKEX:6868
|
CN |
Multiples-Based Value
The
Multiples-Based Value for
Legend Biotech Corp (LEGN)
under the Base Case is
hidden
USD.
Compared with the current market price of 18.2 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LEGN Multiples-Based Value
LOCKED
Multiples Across Competitors
LEGN Competitors Multiples
Legend Biotech Corp Competitors
Legend Biotech Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Legend Biotech Corp
NASDAQ:LEGN
|
3.4B USD | 3.2 | -11.2 | -23 | -18.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.1B USD | 6.1 | 89.2 | 14.8 | 20.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.7B USD | 5.9 | 20.6 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.3 | 28.3 | 21.2 | 22.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD | 5.6 | 18 | 13.4 | 15.3 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR | 11.7 | 37.6 | 40.6 | 41.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3 | 33.2 | 11.2 | 14 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
